Allograft Injection for Degenerative Disc Disease

This policy addresses intradiscal injection of nucleus pulposus allograft with viable cells (allograft injection) for treatment of degenerative disc disease and chronic low back pain. It applies to patients who have failed conservative therapies (e.g., rest, analgesics, physical therapy, epidural steroid injections) but states the procedure is experimental, investigational and not covered due to insufficient clinical evidence and regulatory/safety concerns (unclear HCT/P minimal‑manipulation and homologous‑use compliance).

"Intradiscal injection of nucleus pulposus allograft with viable cells for treatment of degenerative disc disease is considered experimental, investigational and/or unproven and has no covered indic..."

Sign up to see full coverage criteria, indications, and limitations.